Agilent Buys Electrophoresis Company
Lab901’s system provides quality control in next-generation sequencing and gene expression workflows, for which Agilent also supplies other sample preparation products. The system can provide results within one minute per sample.
Santa Clara, CA 2/28/11—Agilent has acquired Lab901, a provider of electrophoresis equipment and consumables, for an undisclosed amount. Lab901 develops and markets the TapeStation benchtop electrophoresis instrument and Screen Tape consumables and reagents. “With the addition of Lab901’s outstanding technology and talented team, Agilent can now address customer needs across the entire span of electrophoresis life science applications—from semi-automated to 96-well-plate compatible workflows,” commented Patrick Kaltenbach, vice president of Agilent’s Liquid Phase Separations business. Based in Edinburgh, UK, Lab901 has 45 employees.
